Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) reduce the need for red blood cell transfusions; however, they increase the risk of thromboembolic events and mortality. The impact of ESAs on quality of life (QoL) is controversial and led to different recommendations of medical societies and aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohlius, J, Tonia, T, Nüesch, E, Jüni, P, Fey, M F, Egger, M, Bernhard, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090721/
https://www.ncbi.nlm.nih.gov/pubmed/24743705
http://dx.doi.org/10.1038/bjc.2014.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090721/
https://www.ncbi.nlm.nih.gov/pubmed/24743705
http://dx.doi.org/10.1038/bjc.2014.171

Ejemplares similares